While this effect has been primarily observed in the GI tract, there is evidence for similar benefit in cardiovascular, neurological, and muscle tissues, suggesting that BPC-157 may be used as both a therapy in the setting of stroke and heart attack as well as a probative peptide for understanding how to promote healing following ischemic injury [5], [6]
However, it does have prescription approval in some countries for anxiety disorders, which is promising for future approval
At Perfect B, we prescribe the injectable form for greater bioavailability and dosing precision
Fast absorption injectable formula for quick results
How is psoriatic arthritis different from rheumatoid arthritis
The CagriSema amylin+GLP-1 combination achieves effects comparable to Retatrutide monotherapy, but Retatrutide has a stronger standalone effect (24 % in Phase 2)